Literature DB >> 12023934

Short-term regulation of PDE4 activity.

V Manganiello1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12023934      PMCID: PMC1573368          DOI: 10.1038/sj.bjp.0704741

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  10 in total

1.  mAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module.

Authors:  K L Dodge; S Khouangsathiene; M S Kapiloff; R Mouton; E V Hill; M D Houslay; L K Langeberg; J D Scott
Journal:  EMBO J       Date:  2001-04-17       Impact factor: 11.598

2.  UCR1 and UCR2 domains unique to the cAMP-specific phosphodiesterase family form a discrete module via electrostatic interactions.

Authors:  M B Beard; A E Olsen; R E Jones; S Erdogan; M D Houslay; G B Bolger
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

Review 3.  Cyclic nucleotide phosphodiesterases and their role in endocrine cell signaling.

Authors:  Celine Mehats; Carsten B Andersen; Marcello Filopanti; S L Catherine Jin; Marco Conti
Journal:  Trends Endocrinol Metab       Date:  2002 Jan-Feb       Impact factor: 12.015

Review 4.  Cyclic nucleotide phosphodiesterases.

Authors:  D M Essayan
Journal:  J Allergy Clin Immunol       Date:  2001-11       Impact factor: 10.793

Review 5.  Phosphodiesterase isozymes: molecular targets for novel antiasthma agents.

Authors:  T J Torphy
Journal:  Am J Respir Crit Care Med       Date:  1998-02       Impact factor: 21.405

Review 6.  The multienzyme PDE4 cyclic adenosine monophosphate-specific phosphodiesterase family: intracellular targeting, regulation, and selective inhibition by compounds exerting anti-inflammatory and antidepressant actions.

Authors:  M D Houslay; M Sullivan; G B Bolger
Journal:  Adv Pharmacol       Date:  1998

Review 7.  The molecular biology of cyclic nucleotide phosphodiesterases.

Authors:  M Conti; S L Jin
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1999

8.  Activation of the cAMP-specific phosphodiesterase PDE4D3 by phosphorylation. Identification and function of an inhibitory domain.

Authors:  J Lim; G Pahlke; M Conti
Journal:  J Biol Chem       Date:  1999-07-09       Impact factor: 5.157

9.  Long PDE4 cAMP specific phosphodiesterases are activated by protein kinase A-mediated phosphorylation of a single serine residue in Upstream Conserved Region 1 (UCR1).

Authors:  Simon J MacKenzie; George S Baillie; Ian McPhee; Carolynn MacKenzie; Rachael Seamons; Theresa McSorley; Jenni Millen; Matthew B Beard; Gino van Heeke; Miles D Houslay
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

10.  A family of human phosphodiesterases homologous to the dunce learning and memory gene product of Drosophila melanogaster are potential targets for antidepressant drugs.

Authors:  G Bolger; T Michaeli; T Martins; T St John; B Steiner; L Rodgers; M Riggs; M Wigler; K Ferguson
Journal:  Mol Cell Biol       Date:  1993-10       Impact factor: 4.272

  10 in total
  2 in total

Review 1.  The cyclic AMP phenotype of fragile X and autism.

Authors:  Daniel J Kelley; Anita Bhattacharyya; Garet P Lahvis; Jerry C P Yin; Jim Malter; Richard J Davidson
Journal:  Neurosci Biobehav Rev       Date:  2008-06-17       Impact factor: 8.989

Review 2.  Function of cAMP scaffolds in obstructive lung disease: Focus on epithelial-to-mesenchymal transition and oxidative stress.

Authors:  Haoxiao Zuo; Isabella Cattani-Cavalieri; Samuel Santos Valença; Nshunge Musheshe; Martina Schmidt
Journal:  Br J Pharmacol       Date:  2019-03-18       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.